Provider perspectives on clinical decision support to improve HIV prevention in pediatric primary care: a multiple methods study.

HIV Implementation science Implicit bias Pediatrics Pre-exposure prophylaxis Primary care

Journal

Implementation science communications
ISSN: 2662-2211
Titre abrégé: Implement Sci Commun
Pays: England
ID NLM: 101764360

Informations de publication

Date de publication:
21 Feb 2023
Historique:
received: 26 08 2022
accepted: 25 01 2023
entrez: 22 2 2023
pubmed: 23 2 2023
medline: 23 2 2023
Statut: epublish

Résumé

Clinical decision support (CDS) is a promising intervention for improving uptake of HIV testing and pre-exposure prophylaxis (PrEP). However, little is known regarding provider perspectives on acceptability, appropriateness, and feasibility of CDS for HIV prevention in pediatric primary care, a key implementation setting. This was a cross-sectional multiple methods study utilizing surveys and in-depth interviews with pediatricians to assess acceptability, appropriateness, and feasibility of CDS for HIV prevention, as well as to identify contextual barriers and facilitators to CDS. Qualitative analysis utilized work domain analysis and a deductive coding approach grounded in the Consolidated Framework of Implementation Research. Quantitative and qualitative data were merged to develop an Implementation Research Logic Model to conceptualize implementation determinants, strategies, mechanisms, and outcomes of potential CDS use. Participants (n = 26) were primarily white (92%), female (88%), and physicians (73%). Using CDS to improve HIV testing and PrEP delivery was perceived as highly acceptable (median score 5), IQR [4-5]), appropriate (5, IQR [4-5]), and feasible (4, IQR [3.75-4.75]) using a 5-point Likert scale. Providers identified confidentiality and time constraints as two key barriers to HIV prevention care spanning every workflow step. With respect to desired CDS features, providers sought interventions that were integrated into the primary care workflow, standardized to promote universal testing yet adaptable to the level of a patient's HIV risk, and addressed providers' knowledge gaps and bolstered self-efficacy in providing HIV prevention services. This multiple methods study indicates that clinical decision support in the pediatric primary care setting may be an acceptable, feasible, and appropriate intervention for improving the reach and equitable delivery of HIV screening and PrEP services. Design considerations for CDS in this setting should include deploying CDS interventions early in the visit workflow and prioritizing standardized but flexible designs.

Sections du résumé

BACKGROUND BACKGROUND
Clinical decision support (CDS) is a promising intervention for improving uptake of HIV testing and pre-exposure prophylaxis (PrEP). However, little is known regarding provider perspectives on acceptability, appropriateness, and feasibility of CDS for HIV prevention in pediatric primary care, a key implementation setting.
METHODS METHODS
This was a cross-sectional multiple methods study utilizing surveys and in-depth interviews with pediatricians to assess acceptability, appropriateness, and feasibility of CDS for HIV prevention, as well as to identify contextual barriers and facilitators to CDS. Qualitative analysis utilized work domain analysis and a deductive coding approach grounded in the Consolidated Framework of Implementation Research. Quantitative and qualitative data were merged to develop an Implementation Research Logic Model to conceptualize implementation determinants, strategies, mechanisms, and outcomes of potential CDS use.
RESULTS RESULTS
Participants (n = 26) were primarily white (92%), female (88%), and physicians (73%). Using CDS to improve HIV testing and PrEP delivery was perceived as highly acceptable (median score 5), IQR [4-5]), appropriate (5, IQR [4-5]), and feasible (4, IQR [3.75-4.75]) using a 5-point Likert scale. Providers identified confidentiality and time constraints as two key barriers to HIV prevention care spanning every workflow step. With respect to desired CDS features, providers sought interventions that were integrated into the primary care workflow, standardized to promote universal testing yet adaptable to the level of a patient's HIV risk, and addressed providers' knowledge gaps and bolstered self-efficacy in providing HIV prevention services.
CONCLUSIONS CONCLUSIONS
This multiple methods study indicates that clinical decision support in the pediatric primary care setting may be an acceptable, feasible, and appropriate intervention for improving the reach and equitable delivery of HIV screening and PrEP services. Design considerations for CDS in this setting should include deploying CDS interventions early in the visit workflow and prioritizing standardized but flexible designs.

Identifiants

pubmed: 36810099
doi: 10.1186/s43058-023-00394-7
pii: 10.1186/s43058-023-00394-7
pmc: PMC9945664
doi:

Types de publication

Journal Article

Langues

eng

Pagination

18

Subventions

Organisme : NIMH NIH HHS
ID : K23 MH119976
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI045008
Pays : United States
Organisme : Interdisciplinary Research Careers in Women's Health Pilot Award
ID : K12-HD085848-01
Organisme : NIMH NIH HHS
ID : K23MH119976
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Am J Prev Med. 2021 Nov;61(5 Suppl 1):S60-S72
pubmed: 34686293
J Pediatr. 2012 May;160(5):719-24
pubmed: 22364853
Implement Sci. 2017 Aug 29;12(1):108
pubmed: 28851459
MMWR Suppl. 2020 Aug 21;69(1):1-10
pubmed: 32817611
Ann Epidemiol. 2018 Dec;28(12):841-849
pubmed: 29983236
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187
pubmed: 34292926
Adv Health Sci Educ Theory Pract. 2015 Dec;20(5):1255-62
pubmed: 25771742
Med Decis Making. 2010 Mar-Apr;30(2):246-57
pubmed: 19726783
J Am Med Inform Assoc. 2005 Jul-Aug;12(4):438-47
pubmed: 15802482
JAMA Netw Open. 2018 Jul 6;1(3):e180818
pubmed: 30646039
MMWR Morb Mortal Wkly Rep. 2021 Nov 26;70(47):1635-1639
pubmed: 34818317
PLoS One. 2014 Sep 08;9(9):e107104
pubmed: 25198577
AIDS Patient Care STDS. 2016 Jul;30(7):339-48
pubmed: 27410497
Sex Transm Dis. 2021 Apr 1;48(4):208-214
pubmed: 33492089
Pediatrics. 2010 Apr;125(4):e770-7
pubmed: 20231191
AIDS Patient Care STDS. 2020 Mar;34(3):111-123
pubmed: 32109141
J Am Med Inform Assoc. 2019 Jan 1;26(1):66-70
pubmed: 30445621
J Am Med Inform Assoc. 2005 Jul-Aug;12(4):365-76
pubmed: 15802474
Pediatrics. 2013 Jun;131(6):1114-24
pubmed: 23650297
Curr HIV/AIDS Rep. 2020 Dec;17(6):643-653
pubmed: 32920764
Implement Sci. 2020 Sep 25;15(1):84
pubmed: 32988389
Pediatrics. 2015 Apr;135(4):e965-73
pubmed: 25755233
Rev Lat Am Enfermagem. 2007 Sep-Oct;15(5):1046-9
pubmed: 18157461
AIDS Behav. 2021 Oct;25(10):3057-3073
pubmed: 33830327
Pediatrics. 2009 Jul;124(1):159-69
pubmed: 19564296
Ergonomics. 1998 Nov;41(11):1618-41
pubmed: 9819578
JAMA Intern Med. 2013 Sep 23;173(17):1584-91
pubmed: 23896675
AIDS. 2017 Mar 13;31(5):731-734
pubmed: 28060019
AIDS Educ Prev. 2017 Jun;29(3):205-217
pubmed: 28650227
J Int AIDS Soc. 2022 Feb;25(2):e25867
pubmed: 35192740
MMWR Morb Mortal Wkly Rep. 2019 Sep 20;68(37):801-806
pubmed: 31536484
Nat Rev Microbiol. 2004 Jan;2(1):33-42
pubmed: 15035007
J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):36-39
pubmed: 30531295
Implement Sci. 2014 Mar 26;9:39
pubmed: 24669765
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211044357
pubmed: 34476999
J Adolesc Health. 2022 Mar;70(3):435-441
pubmed: 34887198
J Pediatr. 2014 Aug;165(2):343-7
pubmed: 24840761
Implement Sci Commun. 2020 Apr 30;1:42
pubmed: 32885199
Int J Med Inform. 2017 Aug;104:56-64
pubmed: 28599817
Int J Environ Res Public Health. 2019 Jul 30;16(15):
pubmed: 31366058
Am J Public Health. 2022 Jan;112(1):135-143
pubmed: 34936422
BMJ Open. 2021 Jan 7;11(1):e040817
pubmed: 33414144
J Acquir Immune Defic Syndr. 2021 Oct 1;88(2):165-172
pubmed: 34506359
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
AIDS Behav. 2022 Oct;26(10):3422-3435
pubmed: 35445994
Pediatrics. 2020 Apr;145(4):
pubmed: 32179661
J Am Med Inform Assoc. 2003 Nov-Dec;10(6):523-30
pubmed: 12925543
Pediatrics. 2007 Oct;120(4):707-14
pubmed: 17908756
Acad Emerg Med. 2016 Mar;23(3):297-305
pubmed: 26763939

Auteurs

Julia Pickel (J)

Wake Forest University School of Medicine, Winston-Salem, NC, USA.

Alexander G Fiks (AG)

Clinical Futures and the Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Dean Karavite (D)

Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Pegah Maleki (P)

Department of Oncology, University Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Rinad S Beidas (RS)

Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Nadia Dowshen (N)

Clinical Futures and the Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Division of Adolescent Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Danielle Petsis (D)

Division of Adolescent Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Robert Gross (R)

Department of Medicine (Infectious Diseases), University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Sarah M Wood (SM)

Clinical Futures and the Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA. woodlab@chop.edu.
Division of Adolescent Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA. woodlab@chop.edu.
Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. woodlab@chop.edu.

Classifications MeSH